Evidence map›Paper›PMID 39747157›Full record

ArticleScientific reports2025

Importance of reference group selection in the evaluation of cancer incidence.

Alexandra K Mueller, Brandon Vaeth, Andrew C Todd, Christopher R Dasaro, Jiehui Li, Baozhen Qiao, Paolo Boffetta, David J Prezant, Charles B Hall, David G Goldfarb and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alexandra K Mueller *Bureau of Health Services, World Trade Center Health Program, Fire Department of the City of New York, Brooklyn, NY, USA.ORCID 0000-0003-4028-6720
Brandon Vaeth *Bureau of Health Services, World Trade Center Health Program, Fire Department of the City of New York, Brooklyn, NY, USA.
Andrew C ToddWorld Trade Center Health Program General Responder Data Center, Department of Environmental Medicine and Climate Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-7864-009X
Christopher R DasaroWorld Trade Center Health Program General Responder Data Center, Department of Environmental Medicine and Climate Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-4942-7916
Jiehui LiNew York City Department of Health and Mental Hygiene, World Trade Center Health Registry, Long Island City, NY, USA.ORCID 0000-0002-7812-8878
Baozhen QiaoNew York State Department of Health, Bureau of Cancer Epidemiology, Albany, NY, USA.ORCID 0000-0002-8407-7835
Paolo BoffettaStony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA.ORCID 0000-0002-3811-2791
David J PrezantBureau of Health Services, World Trade Center Health Program, Fire Department of the City of New York, Brooklyn, NY, USA.ORCID 0000-0001-9562-0330
Charles B HallDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.ORCID 0000-0001-9982-8120
David G Goldfarb *Bureau of Health Services, World Trade Center Health Program, Fire Department of the City of New York, Brooklyn, NY, USA.ORCID 0000-0003-2682-7543
Rachel Zeig-Owens *Bureau of Health Services, World Trade Center Health Program, Fire Department of the City of New York, Brooklyn, NY, USA. Rachel.Zeig-Owens@fdny.nyc.gov.ORCID 0000-0002-8679-2306

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI STEVEN C. ALMO · 1985 to 2026
$111.2M
ATSDR CDC HHS U50/ATU272750National Cancer Institute, United States P30 CA013330, U58 DP006309NCCDPHP CDC HHS NU58DP006344NCI NIH HHS HHSN261201800009CNCI NIH HHS HHSN261201800009INCI NIH HHS HHSN261201800015CNCI NIH HHS HHSN261201800015INCI NIH HHS HHSN261201800032CNCI NIH HHS HHSN261201800032INCI NIH HHS P30 CA013330NIOSH CDC HHS U01 OH011315NIOSH CDC HHS U01OH011315, U01 OH011932, U01 OH011681, U01 OH011931, U01 OH011480, 200-2011-39378, 200-2017-93325, 200-2017-93326NIOSH CDC HHS U01 OH011480NIOSH CDC HHS U01 OH011681NIOSH CDC HHS U01 OH011931NIOSH CDC HHS U01 OH011932
6 · The paper itself

Abstract

Elevated cancer incidence has been reported among World Trade Center (WTC)-exposed responders, with some incidence rate ratios (IRRs) varying over time. This study describes the influence that different reference populations have on relative cancer incidence and temporal trends. Participants from the WTC Combined Rescue/Recovery Cohort (n = 65,691) were observed between 1/1/2002 and 12/31/2015 using data obtained from 13 state cancer registries. Poisson regression was used to estimate IRRs controlling for age, race/ethnicity, and calendar year. IRRs and change-points were estimated using three reference populations (New York City (NYC), New York State (NYS), and a US population). IRRs for each cancer site varied in magnitude. Prostate and thyroid cancer IRRs were significantly greater in WTC-exposed responders, while colon and lung cancer IRRs were significantly lower compared with NYC, NYS, and US population reference groups. The range of IRRs varied by reference population. Mixed findings were observed for other cancers, as results were dependent on the reference group used. A significant change-point was found only for prostate cancer, and only when compared to a US population. Our findings suggest that reference population selection will influence the IRR, timing, and statistical significance of change-point estimation, varying with follow-up length.

Indexed as

NeoplasmsSeptember 11 Terrorist AttacksAdultAgedEmergency RespondersFemaleHumansIncidenceMaleMiddle AgedNew York CityOccupational ExposureRegistriesUnited StatesCancer incidenceReference populationWorld Trade Center disaster

Identifiers

PMID39747157
PMCPMC11696304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.